BioMed Central Full text When Failure Should Be the Option: "When failure should be the option"
about possible yield from failed phase II studies
- drugs found ineffective, but safe
? maybe more effective for other target, other disease """"!!!!!
Prihlásiť na odber:
Zverejniť komentáre (Atom)
Žiadne komentáre:
Zverejnenie komentára